Aptar continues
expansion with additional pharma plant near Mumbai, India
Sanjay Kapote, President of Aptar Pharma India
and Southeast Asia
Crystal Lake, Illinois : AptarGroup, Inc., a global leader
in drug and consumer product dosing, dispensing and protection technologies,
today announced the groundbreaking ceremony of its new pharma plant in Taloja,
India, near Mumbai. The facility will help Aptar continue to meet the growing
demands of the pharmaceutical industry in India.
Sanjay
Kapote, President of Aptar Pharma India and Southeast Asia, commented, “Over
the past decade, Aptar Pharma has achieved strong and consistent growth, thanks
to our reliable products, regulatory expertise and knowledge of patient needs.
This additional plant in Taloja will further strengthen our ability to
efficiently deliver high-quality, innovative products and reinforces our
commitment to investing in the pharma end markets. Additionally, we are keen on
exploring acquisitions in the pharma space. We see significant growth potential
within the pharmaceutical industry in India and the potential to expand our
position in the market.”
The
new state-of-the-art facility will expand the company’s existing footprint in
the region while adding additional local production of several technologies
including Aptar’s pressurized metered-dose inhaler (pMDI) valve, as well as
breath-actuated devices and single-dose nasal sprays.
The
new Taloja plant will also enable Aptar to meet the region’s growing needs by
adding an additional 4400 m2 of
manufacturing footprint and will be constructed adjacent to the existing Aptar
Mumbai facility that opened in 2023.
Aptar
is committed to strengthening its roots in the region through both organic
growth and strategic acquisitions. The company looks for potential acquisitions
and partnerships with IP driven, pharma packaging companies to continue the
expansion of their drug dosing, dispensing and protection offerings.
About Aptar
Aptar
is a global leader in drug and consumer product dosing, dispensing and
protection technologies. Aptar serves a number of attractive end markets
including pharmaceutical, beauty, food, beverage, personal care and home care.
Using market expertise, proprietary design, engineering and science to create
innovative solutions for many of the world’s leading brands, Aptar in turn
makes a meaningful difference in the lives, looks, health and homes of millions
of patients and consumers around the world. Aptar is headquartered in Crystal
Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more
information, visit www.aptar.com.
This press
release contains forward-looking statements. Forward-looking statements
generally can be identified by the fact that they do not relate strictly to
historical or current facts and by use of words such as “expects,”
“anticipates,” “believes,” “estimates,” “future,” “potential,” “continues” and
other similar expressions or future or conditional verbs such as “will,”
“should,” “would” and “could” are intended to identify such forward-looking
statements. Forward-looking statements are made pursuant to the safe harbor
provisions of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934 and are based on our beliefs as well as
assumptions made by and information currently available to us. Accordingly, our
actual results or other events may differ materially from those expressed or
implied in such forward-looking statements due to known or unknown risks and
uncertainties that exist in our operations and business environment including,
but not limited to: the successful integration of acquisitions; the regulatory
environment; and competition, including technological advances. For additional
information on these and other risks and uncertainties, please see our filings
with the Securities and Exchange Commission, including the discussion under
“Risk Factors” and “Management’s Discussion and Analysis of Financial Condition
and Results of Operations” in our Form 10-K and Forms 10-Q. We undertake no
obligation to update publicly any forward-looking statements, whether as a
result of new information, future events or otherwise, except as otherwise
required by law.
Aptar
Investor Relations Contact:
Mary
Skafidas
+1
347 351 6407
Aptar Media Contact
Katie Reardon
+1 815 479 5671
For further media
queries, please contact:
Sonia
Kulkarni, Hunk Golden and Media
Mobile: 9820184099 |
Email: sonia.kulkarni@hunkgolden.in